Adverse dermatologic effects of erdafitinib in a patient with metastatic urothelial carcinoma. Johnson M, Clark M, Whittington C, Newton E, et al. Dermatol Online J 2026;32.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Johnson M, Clark M, Whittington C, Newton E, et al. Adverse dermatologic effects of erdafitinib in a patient with metastatic urothelial carcinoma. Dermatol Online J 2026;32.
PMID: 42246324